Total Payments
$13,147
2024 Payments
$576.51
Companies
11
Transactions
36
Medicare Patients
1,170
Medicare Billing
$133,323
Payment Breakdown by Category
Other$9,800 (74.5%)
Food & Beverage$2,125 (16.2%)
Travel$1,015 (7.7%)
Education$207.62 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,800 | 6 | 74.5% |
| Food and Beverage | $2,125 | 25 | 16.2% |
| Travel and Lodging | $1,015 | 2 | 7.7% |
| Education | $207.62 | 3 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $11,455 | 16 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $432.45 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $419.72 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $238.42 | 2 | $0 (2018) |
| Insmed, Inc. | $178.02 | 3 | $0 (2022) |
| Inari Medical, Inc. | $141.92 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $94.63 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $80.55 | 1 | $0 (2022) |
| Baxter Healthcare | $59.26 | 2 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $30.26 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $576.51 | 6 | Mallinckrodt Hospital Products Inc. ($200.58) |
| 2023 | $324.56 | 4 | Mallinckrodt Hospital Products Inc. ($231.87) |
| 2022 | $244.61 | 4 | AstraZeneca Pharmaceuticals LP ($124.00) |
| 2021 | $166.13 | 2 | Insmed, Inc. ($166.13) |
| 2020 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2018 | $5,666 | 8 | Genentech USA, Inc. ($5,544) |
| 2017 | $6,045 | 11 | Genentech USA, Inc. ($5,910) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $94.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/01/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: CRITICAL CARE | ||||||
| 05/22/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $141.92 | General |
| Category: VTE | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $109.12 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $98.33 | General |
| Category: CRITICAL CARE | ||||||
| 02/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Cardiology | ||||||
| 08/22/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: Airway Clearance Device | ||||||
| 05/31/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $116.04 | General |
| Category: CRITICAL CARE | ||||||
| 04/14/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $115.83 | General |
| Category: CRITICAL CARE | ||||||
| 01/23/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $61.60 | General |
| Category: Rare Disease | ||||||
| 11/02/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $80.55 | General |
| Category: Oncology | ||||||
| 10/26/2022 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Renal | ||||||
| 07/28/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Rare Disease | ||||||
| 01/20/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Respiratory | ||||||
| 12/10/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Respiratory | ||||||
| 09/09/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $91.14 | General |
| Category: Respiratory | ||||||
| 02/27/2020 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 11/29/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $121.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Immunology | ||||||
| 08/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $100.11 | General |
| Category: Immunology | ||||||
| 04/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,450.00 | General |
| Category: Immunology | ||||||
| 04/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Travel and Lodging | Cash or cash equivalent | $790.60 | General |
| Category: Immunology | ||||||
| 04/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $241.62 | General |
| Category: Immunology | ||||||
| 04/21/2018 | Genentech USA, Inc. | Esbriet (Biological) | Travel and Lodging | Cash or cash equivalent | $224.02 | General |
| Category: Immunology | ||||||
| 04/13/2018 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 426 | 510 | $326,289 | $53,889 |
| 2022 | 11 | 402 | 456 | $173,476 | $32,089 |
| 2021 | 9 | 213 | 313 | $144,526 | $30,458 |
| 2020 | 6 | 129 | 174 | $64,043 | $16,886 |
Total Patients
1,170
Total Services
1,453
Medicare Billing
$133,323
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 66 | 114 | $197,028 | $26,273 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 63 | $24,372 | $6,602 | 27.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 46 | 48 | $39,844 | $5,583 | 14.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 41 | $18,741 | $5,287 | 28.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $16,475 | $3,878 | 23.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 23 | $7,231 | $1,970 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $7,591 | $1,895 | 25.0% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 29 | 29 | $4,782 | $707.31 | 14.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 43 | 43 | $3,147 | $552.72 | 17.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 53 | 53 | $2,641 | $514.63 | 19.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 37 | 37 | $2,888 | $404.28 | 14.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 25 | 25 | $1,549 | $222.25 | 14.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 48 | $80,368 | $11,531 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 74 | $27,921 | $7,761 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $12,752 | $3,113 | 24.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 24 | $10,638 | $2,669 | 25.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 15 | 15 | $12,132 | $1,800 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 13 | 13 | $8,110 | $1,756 | 21.6% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 48 | 50 | $8,000 | $1,202 | 15.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 55 | 55 | $3,876 | $703.03 | 18.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 71 | 72 | $3,476 | $678.78 | 19.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 56 | 56 | $4,230 | $611.23 | 14.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 32 | 33 | $1,973 | $265.25 | 13.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 91 | $38,870 | $10,328 | 26.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 22 | 39 | $63,357 | $9,498 | 15.0% |
About Dr. Thomas Kelley, DO
Dr. Thomas Kelley, DO is a Pulmonary Disease healthcare provider based in Bend, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730293317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kelley, DO has received a total of $13,147 in payments from pharmaceutical and medical device companies, with $576.51 received in 2024. These payments were reported across 36 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,800).
As a Medicare-enrolled provider, Kelley has provided services to 1,170 Medicare beneficiaries, totaling 1,453 services with total Medicare billing of $133,323. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Bend, OR
- Active Since 08/19/2006
- Last Updated 04/15/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730293317
Products in Payments
- Esbriet (Biological) $11,455
- TERLIVAZ (Drug) $432.45
- NUCALA (Biological) $238.42
- ANDEXXA (Biological) $185.60
- Arikayce (Drug) $178.02
- FLOWTRIEVER CATHETER, S (Device) $141.92
- TAGRISSO (Drug) $125.00
- TEZSPIRE (Biological) $109.12
- DUPIXENT (Biological) $94.63
- OPDIVO (Biological) $80.55
- Hillrom - Life 2000 Ventilation System (Device) $31.09
- OPSUMIT (Drug) $30.26
- Renal - Acute (Device) $28.17
- ALAIR (Device) $17.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bend
Matthew Hegewald, Md, MD
Pulmonary Disease — Payments: $166,361
Pulmonary Disease $166,361
Louis D'avignon, Md, MD
Pulmonary Disease — Payments: $4,093
Pulmonary Disease $4,093
Dr. Mark Bradford, M.d, M.D
Pulmonary Disease — Payments: $1,403
Pulmonary Disease $1,403
Richard Maunder, Md, MD
Pulmonary Disease
Pulmonary Disease
Dr. Alan Ertle, M.d, M.D
Pulmonary Disease
Pulmonary Disease
Nathan Rasor
Pulmonary Disease
Pulmonary Disease